Home > With Plethora Of New Myeloma Treatments, MMRF Study Aims To Better Guide Use
With Plethora Of New Myeloma Treatments, MMRF Study Aims To Better Guide Use
The MMRF aims to incorporate a variety of new bispecific antibodies, cell therapies, checkpoint inhibitors and novel small molecules into the Horizon study.
This site uses cookies and other tracking technologies to assist with navigation and your ability to provide feedback, analyze your use of our products and services, assist with our promotional and marketing efforts, and provide content from third parties.OkPrivacy policy
